Japanese pharmaceutical firm Eisai Co. is set to start clinical trials in the United States of its experimental drug eritoran in the battle against coronavirus, with results potentially available by the year-end, the company said Wednesday. Eisai will test eritoran, initially developed to treat severe ...
61 articles published
Business sentiment among large Japanese manufacturers in June plunged to the lowest level since June 2009 due to the economic fallout from the novel coronavirus pandemic, the Bank of Japan's tankan survey showed Wednesday. The key index measuring confidence among companies including carmakers and electronics ...